Besides somatic alterations, germline mutations in the human TP53 gene constitutes an enhanced risk of developing a wide spectrum of early-onset cancers, as they are one of the underlying causes of a rare familial cancer disorder called Li-Fraumeni syndrome [5,6]. The gene discussed is TP53; the disease is cancer.